Food « Weekly Sauce

Products may be contaminated with bacteria that can cause serious infections read on >

The weight-loss drug Wegovy may lower the risk of heart attack, stroke or death more than similar medications, according to new research from its maker, Novo Nordisk. In a study of more than 21,000 patients with obesity and heart disease but no diabetes, those taking Wegovy — which contains the active ingredient semaglutide — saw… read on > read on >

Wrong dressing packets that were included contain undeclared sesame and soy read on >

Leqembi Iqlik allows for at-home maintenance dosing after initial 18 months of intravenous dosing read on >

To increase transparency, the agency is publishing data from the FDA Adverse Event Reporting System daily rather than quarterly read on >

At least 95 people in 14 states have been sickened in a salmonella outbreak tied to recalled eggs, federal health officials say. Country Eggs LLC, based in Lucerne Valley, Calif., has recalled its large, brown cage-free “sunshine yolks” and “omega-3 golden yolks” eggs. Production at the facility has been suspended, according to the U.S. Food… read on > read on >

Medical education organizations have until Sept. 10 to submit plans detailing their nutrition education commitments read on >

Fatty foods might contribute to asthma in children, a new study says. Fats found in certain foods are linked to neutrophilic asthma, a non-allergic type of asthma triggered by microbial and bacterial proteins, researchers reported Aug. 27 in the journal Science Translational Medicine. Specifically, a type of saturated fatty acid called stearic acid – often… read on > read on >

Enjoy a pint of beer, a glass of wine or a dram of whiskey? Then make sure you have some healthy eats and a good dose of exercise on the side, a new study says. A healthy diet and regular physical activity can protect your liver at least partially from the harmful effects of alcohol,… read on > read on >

Eli Lilly says its new once-daily pill, orforglipron, helped people lose significant weight and lower blood sugar in a late-stage clinical trial. The company plans to seek global regulatory approval later this year. The study included people with overweight, obesity and type 2 diabetes. Participants who took the highest dose of the drug (36 milligrams)… read on > read on >